title: How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis?
authors.affiliation: Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-8857, USA. Kathleen.Wyne@UTSouthwestern.edu
authors.forename: Kathleen L
authors.initials: KL
authors.lastname: Wyne
authors.forename: Steven
authors.initials: S
authors.lastname: Fishbane
authors.forename: Geoffrey A
authors.initials: GA
authors.lastname: Block
authors.forename: Karen
authors.initials: K
authors.lastname: Warburton
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Berns
authors.forename: Alicia M
authors.initials: AM
authors.lastname: Neu
authors.forename: Bradley A
authors.initials: BA
authors.lastname: Warady
mesh_terms: D002908:Chronic Disease; D003928:Diabetic Nephropathies / Q000628:therapy; D018450:Disease Progression; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007674:Kidney Diseases / Q000150:complications / Q000628:therapy*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D006435:Renal Dialysis